Dr. Hae-Sung Kwak, President of Mini She Dental Hospital, has been named a 2025 Key Opinion Leader (KOL) by global dental materials company Evocla.
Headquartered in Liechtenstein, Evocla is a global company specializing in the research, development and production of composite resins, cements, adhesives and other materials, including all-composite, all-ceramic and artificial teeth, with a presence in Korea through Evocla Korea.
This KOL selection is particularly significant because it is a formal agreement that goes beyond mere collaboration. Kwak has spoken at the request of companies such as 3M, Austem, and Visco in the past, but this is the first time he has been contracted directly by a global headquarters.
Selected as one of 13 KOLs in Korea, Mr. Kwak will spend a year expanding his global network by traveling to Evocla’s headquarters and giving lectures on bonding.
“This KOL selection is a recognition of the expertise and reliability of Mini Shi Dental Hospital by a global company,” said Dr. Kwak. “We will continue to work with Evocla to share information on the latest dental technologies and materials with the Korean dental community and contribute to improving the quality of patient care.”
